Literature DB >> 7634440

Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation.

J Ferrières1, J Lambert, S Lussier-Cacan, J Davignon.   

Abstract

BACKGROUND: Familial hypercholesterolemia (FH), an autosomal codominant disease, is characterized by high levels of LDL cholesterol and a high incidence of coronary artery disease (CAD). To date, genetic heterogeneity has hindered the proper assessment of the relation between risk factors and CAD in FH patients. METHODS AND
RESULTS: We studied the association between CAD and common risk factors in a sample of 263 French Canadian FH patients (147 women, 116 men) carrying the same > 10-kb deletion of the LDL receptor gene. Thirty-five women and 54 men had CAD. The mean age of onset of CAD was 45.6 +/- 12.7 years in women and 38.8 +/- 9.4 years in men. Multiple logistic regression analyses were performed to test the association between CAD and age, tendon xanthomas, cigarette smoking, hypertension, diabetes mellitus, apolipoprotein E polymorphism, total plasma cholesterol, triglycerides, VLDL cholesterol, LDL cholesterol, HDL cholesterol, and lipoprotein(a) [Lp(a)]. In FH women, significant multivariate predictors were age (odds ratio, 1.10 for 1 year; P < .0001), VLDL cholesterol (odds ratio, 3.85 for 1 natural log unit; P < .002), and LDL cholesterol (odds ratio, 1.42 for 1 mmol/L; P < .02). In FH men, age (odds ratio, 1.08 for 1 year; P < .0001) and HDL cholesterol (odds ratio, 0.14 for 1 mmol/L; P = .05) were significant predictors of disease. Lp(a) was not a significant predictor in univariate or multivariate analyses.
CONCLUSIONS: This study suggests that increased risk of CAD in FH is not solely due to elevated LDL cholesterol levels and demonstrates a sex-specific lipoprotein influence on CAD in a large sample of FH patients carrying the same LDL receptor gene defect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7634440     DOI: 10.1161/01.cir.92.3.290

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  20 in total

Review 1.  Role of lipid-lowering pharmacotherapy in children.

Authors:  S Tonstad
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

2.  Fatal myocardial infarction at 4.5 years in a case of homozygous familial hypercholesterolaemia.

Authors:  Matthias Gautschi; Mladen Pavlovic; Jean-Marc Nuoffer
Journal:  JIMD Rep       Date:  2011-09-06

3.  A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia.

Authors:  A Cenarro; M Artieda; S Castillo; P Mozas; G Reyes; D Tejedor; R Alonso; P Mata; M Pocoví; F Civeira
Journal:  J Med Genet       Date:  2003-03       Impact factor: 6.318

4.  Role of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia.

Authors:  Valerie Leduc; Lucienne Bourque; Judes Poirier; Robert Dufour
Journal:  Pharmacogenet Genomics       Date:  2016-01       Impact factor: 2.089

5.  Genetic diagnosis of familial hypercholesterolemia is associated with a premature and high coronary heart disease risk.

Authors:  Florent Séguro; Jean-Pierre Rabès; Dorota Taraszkiewicz; Jean-Bernard Ruidavets; Vanina Bongard; Jean Ferrières
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

6.  Genetic variations at ABCG5/G8 genes modulate plasma lipids concentrations in patients with familial hypercholesterolemia.

Authors:  A Garcia-Rios; P Perez-Martinez; F Fuentes; P Mata; J Lopez-Miranda; R Alonso; F Rodriguez; A Garcia-Olid; J Ruano; J M Ordovas; F Perez-Jimenez
Journal:  Atherosclerosis       Date:  2010-01-22       Impact factor: 5.162

Review 7.  Familial hypercholesterolemia--epidemiology, diagnosis, and screening.

Authors:  Siddharth Singh; Vera Bittner
Journal:  Curr Atheroscler Rep       Date:  2015       Impact factor: 5.113

8.  Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice.

Authors:  Marcia L E MacDonald; Roshni R Singaraja; Nagat Bissada; Piers Ruddle; Russell Watts; Joanna M Karasinska; William T Gibson; Catherine Fievet; Jean E Vance; Bart Staels; Michael R Hayden
Journal:  J Lipid Res       Date:  2007-10-24       Impact factor: 5.922

9.  Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia.

Authors:  Jeroen B van der Net; Daniëlla M Oosterveer; Jorie Versmissen; Joep C Defesche; Mojgan Yazdanpanah; Bradley E Aouizerat; Ewout W Steyerberg; Mary J Malloy; Clive R Pullinger; John J P Kastelein; John P Kane; Eric J G Sijbrands
Journal:  Eur Heart J       Date:  2008-07-03       Impact factor: 29.983

10.  Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.

Authors:  H A W Neil; V Seagroatt; D J Betteridge; M P Cooper; P N Durrington; J P Miller; M Seed; R P Naoumova; G R Thompson; R Huxley; S E Humphries
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.